Showing results (251-260 of 312) with videos related to
Sort By:
Pageof 32
ACS Infectious Diseases|July 13, 2019
Cyclipostins and Cyclophostin Analogues as Multitarget Inhibitors That Impair Growth of <i>Mycobacterium abscessus</i>Abdeldjalil Madani, Jeremy N Ridenour, Benjamin P Martin, et al.The Science of the Total Environment|February 3, 2022
Multi-scale approach to biodiversity proxies of biological control service in European farmlandsKévin Tougeron, Eloïse Couthouis, Ronan Marrec, et al.Open Forum Infectious Diseases|August 30, 2021
Risks of Opportunistic Infections in People With Human Immunodeficiency Virus With Cancers Treated With ChemotherapyAlain Makinson, Lesley S Park, Kimberly Stone, et al.Journal of Medical Virology|February 8, 2021
Diagnosis value of SARS-CoV-2 antigen/antibody combined testing using rapid diagnostic tests at hospital admissionNicolas Veyrenche, Karine Bolloré, Amandine Pisoni, et al.BMJ Open|September 3, 2018
Efficacy of cloxacillin versus cefazolin for methicillin-susceptible <i>Staphylococcus aureus</i> bacteraemia (CloCeBa): study protocol for a randomised, controlled, non-inferiority trialCharles Burdet, Paul Loubet, Vincent Le Moing, et al.JCO Clinical Cancer Informatics|March 15, 2021
OSIRIS: A Minimum Data Set for Data Sharing and Interoperability in OncologyJulien Guérin, Yec'han Laizet, Vincent Le Texier, et al.Frontiers in Microbiology|April 20, 2018
Human Genetic Susceptibility to Native Valve <i>Staphylococcus aureus</i> Endocarditis in Patients With <i>S. aureus</i> Bacteremia: Genome-Wide Association StudyKaren Moreau, Alisson Clemenceau, Vincent Le Moing, et al.Journal of the American College of Cardiology|May 26, 2012
Temporal trends in infective endocarditis in the context of prophylaxis guideline modifications: three successive population-based surveysXavier Duval, François Delahaye, François Alla, et al.Chest|April 13, 2013
A proof-of-concept, randomized, controlled trial of omalizumab in patients with severe, difficult-to-control, nonatopic asthmaGilles Garcia, Antoine Magnan, Raphaël Chiron, et al.Respiratory Medicine|August 31, 2010
Omalizumab-induced decrease of FcξRI expression in patients with severe allergic asthmaPascal Chanez, Cécile Contin-Bordes, Gilles Garcia, et al.Pageof 32